Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 642

Israel Institute for Biological Research

An Israeli passport on January 18, 2023. (Nati Shohat/Flash90)
May 21, 2023, 3:06 pm
Police nab suspected passport appointment scalper
Suspect employed at national laboratory involved in issuing passports believed to have booked hundreds of slots, then sold them for cash
By ToI Staff
Vials of a potential coronavirus vaccine are seen on an assembly line in a photograph released by the Israel Institute for Biological Research on October 25, 2020. (Defense Ministry)
March 15, 2023, 12:58 am
Researchers oversold Israeli COVID shot, wasted millions on flop — comptroller
State ombudsman faults Defense Ministry institute for mishandling project and misleading officials on costs, timetable and ability to produce homegrown vaccine
By ToI Staff
Dr. Edo Kon working on the world's first mRNA vaccine for bacteria at Tel Aviv University. (Courtesy of Tel Aviv University)
March 14, 2023, 2:35 pm
Israeli scientists produce world’s first mRNA vaccine for bacteria
By focusing on key differences between viruses and bacteria, researchers elicit strong immune responses in mice against Plague pathogen that killed millions in Middle Ages
By Renee Ghert-Zand
A volunteer in the Phase 2 trial for Israel's coronavirus vaccine, BriLife, at Sheba Medical Center, on December 28, 2020 (courtesy of Sheba Medical Center)
October 2, 2021, 11:45 am
TV: Israeli-made COVID vaccine at least 80% effective, initial results show
Israel Institute for Biological Research indicates over 4 out of 5 volunteers in ongoing clinical trials developed antibodies, Channel 12 reports
By ToI Staff
Anar Ottolenghi receives a dose of coronavirus vaccine developed by the Israel Institute for Biological Research at Jerusalem's Hadassah Ein Kerem Hospital, November 1, 2020 (Courtesy)
September 20, 2021, 1:30 pm
Late but longer-lasting? Israel’s COVID jab aims to ‘find its place in market’
Chairman of NRx, pharmaceutical company completing trials for BriLife, suggests vaccine may even work better against variants
By Ricky Ben-David
Former Mossad chief Tamir Pardo. (Courtesy)
September 1, 2021, 7:00 pm
Ex-Mossad chief joins pharma company commercializing Israeli COVID jab
Tamir Pardo signs on as board member of NRx pharmaceuticals, which is completing trials for BriLife vaccine in Georgia, Ukraine
By Ricky Ben-David
Vials of a potential coronavirus vaccine are seen on an assembly line, in a photograph released by the Israel Institute for Biological Research, on October 25, 2020. (Defense Ministry)
August 21, 2021, 10:09 pm
TV: High dose of Israeli-made vaccine appears to give long-lasting protection
230 people who received such dosage of inoculation, still in trials, do not need to get a booster, but others who had lower dosage do need extra shot
By ToI Staff
Defense Minister Benny Gantz visits a laboratory in the Israel Institute for Biological Research on October 25, 2020. (Defense Ministry)
July 13, 2021, 1:46 am
Israel’s own COVID-19 vaccine to be tested in Georgia, Ukraine and at home
NRx Pharmaceuticals will send inoculation, known as Brilife, to third-stage clinical trials, which will be conducted on tens of thousands of volunteers in Israel and abroad
By ToI Staff
Director of the Institute of Biological Research, Prof. Shmuel Shapira, at the laboratory in Ness Ziona on August 6, 2020. (Ariel Hermoni/ Defense Ministry)
March 23, 2021, 6:37 pm
Report: Leader of embattled homegrown Israeli vaccine effort to step down
Unclear who will replace Shmuel Shapira as head of Institute for Biological Research; rapid inoculation drive has raised doubts about need for domestic shot
By ToI Staff
Prime Minister Benjamin Netanyahu (C) and Defense Minister Benny Gantz (R) speak with Segev Harel, the first volunteer for trials for an experimental Israeli coronavirus vaccine, at Sheba Medical Center, November 1, 2020. (Ariel Hermoni/Defense Ministry)
February 3, 2021, 2:22 pm
First volunteer for Israeli vaccine trials, feted by Netanyahu, got the placebo
Segev Harel, who received much media attention for being 1st to take part in experiment of homegrown inoculation Brilife, says he has since learned he was in the control group
By ToI Staff
Sheba Medical Center nurse Hala Litwin injects a dose into Israel's first human test subject, Segev Harel, as part of trials for Israel's experimental coronavirus vaccine, BriLife, on November 1, 2020. (Defense Ministry)
December 14, 2020, 8:07 pm
Israeli vaccine clears first stage as no major side effects reported
Defense Ministry institute to begin second phase of trials, testing coronavirus vaccine on 1,000 people; third phase expected in spring
By Judah Ari Gross
Vials of a potential coronavirus vaccine are seen on an assembly line in a photograph released by Israel's Institute for Biological Research on October 25, 2020. (Defense Ministry)
November 30, 2020, 6:00 pm
Israel’s COVID-19 vaccine being delayed by red tape, bio institute head laments
Shmuel Shapira of Defense Ministry’s Institute for Biological Research says shot will only be publicly available in summer, admits ‘very minor’ side effects detected in 1st trials
By ToI Staff
Vials of a potential coronavirus vaccine are seen on an assembly line, in a photograph released by the Israel Institute for Biological Research, on October 25, 2020. (Defense Ministry)
November 21, 2020, 3:16 am
Israel’s domestic vaccine expected to be ready for public by summer, report says
Shot produced by Defense Ministry’s Institute for Biological Research is currently undergoing Phase I trials; volunteers have experienced no side effects, Channel 12 says
By ToI Staff
Segev Harel, the first volunteer for trials for Israel's coronavirus vaccine. (Sheba Medical Center)
October 31, 2020, 11:28 pm
Volunteer to receive 1st Israeli vaccine shot hails ‘historic opportunity’
Segev Harel, 26, tapped to get COVID-19 shot at Sheba Hospital on Sunday as clinical trial gets underway
By Nathan Jeffay and ToI Staff
Boaz Kolodner (video screen capture: Ynet)
October 30, 2020, 8:45 pm
Candidate to receive 1st Israeli COVID vaccine dose forced to withdraw
Tests discover Boaz Koldoner has coronavirus antibodies, indicating he already had the virus; he encourages others to volunteer for human trials
By ToI Staff
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.